Craig Johnson

Craig Johnson is the Director at Odonate Therapeutics. Craig has over 25 years of experience in the biotechnology and pharmaceutical industries. Prior to joining Odonate, Craig was the Chief Financial Officer, Senior Vice President of Operations and Secretary at MitoKor, Inc. From 2008 to 2012, they served on the Board of Directors at Ardea Biosciences, Inc. Craig has also served on the Board of Directors at Mimotopes Pty. Ltd. and TorreyPines Therapeutics, Inc.

Craig Johnson has a Bachelor of Business Administration from the University of Michigan-Dearborn and is a Certified Public Accountant.